Clinical Trial Update: Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating atrioventricular node ablation in patients with atrial fibrillation and moderate chronic heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Snippet

Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | Conditions: Heart Failure | Phase 4 | Status: TERMINATED